Empagliflozin reduces the doxorubicine-induced myocardial dysfunction.
28 August 2017 (14:00 - 18:00)
Organised by:
Abstract
Slides
About the speaker
Magna Graecia University of Catanzaro, Catanzaro (Italy)
4 More presentations in this session
Access the full session
The Event
ESC Congress 2017
28 August 2017
14:00 CET
You may be interested in
Congress Session
17 May 2025
Congress Presentation
3 September 2019
Webinar
6 October 2022
